Article info
PDFOriginal research
Ki67 expression as a predictor of chemotherapy outcome in low-grade serous ovarian cancer
- Correspondence to Dr Jacek P Grabowski, Department of Gynecology, Charite Universitatsmedizin Berlin, Berlin 13353, Germany; jacek.grabowski{at}charite.de
Citation
Ki67 expression as a predictor of chemotherapy outcome in low-grade serous ovarian cancer
Publication history
- Received October 1, 2019
- Revision received December 23, 2019
- Accepted December 31, 2019
- First published January 28, 2020.
Article Versions
- You are currently viewing a Previous version of this article (28 January 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.